BE1002295A5 - Medicaments. - Google Patents

Medicaments. Download PDF

Info

Publication number
BE1002295A5
BE1002295A5 BE8900740A BE8900740A BE1002295A5 BE 1002295 A5 BE1002295 A5 BE 1002295A5 BE 8900740 A BE8900740 A BE 8900740A BE 8900740 A BE8900740 A BE 8900740A BE 1002295 A5 BE1002295 A5 BE 1002295A5
Authority
BE
Belgium
Prior art keywords
methyl
drugs
cylco
carbazol
piroxicam
Prior art date
Application number
BE8900740A
Other languages
English (en)
Inventor
Keith Thomas Bunce
Patrick Paul Anthony Humphrey
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of BE1002295A5 publication Critical patent/BE1002295A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne la co-admininstration, en médecine humaine ou vétérinaire, de la 1,2,3,9-tétrahydro-9-méthyl-3-[(2-méthyl-1H-imidazol-1-yl)méthyl]-4H-carbazol-4-one ou d'un de sels ou solvates physiologiquement acceptables et d'un inhibiteur de cylco-oxygénase comme l'indométhacine ou le piroxicam. Les deux ingrédients actifs, qui peuvent être administrés séparément, ou bien simultanément ou bien l'un après l'autre, ou être combinés dans une seule préparation pharmaceutique, sont utiles pour soulager et/ou prévenir les nausées et les vomissements.
BE8900740A 1988-07-07 1989-07-06 Medicaments. BE1002295A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888816187A GB8816187D0 (en) 1988-07-07 1988-07-07 Medicaments

Publications (1)

Publication Number Publication Date
BE1002295A5 true BE1002295A5 (fr) 1990-11-20

Family

ID=10640032

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900740A BE1002295A5 (fr) 1988-07-07 1989-07-06 Medicaments.

Country Status (14)

Country Link
US (1) US4983621A (fr)
JP (1) JPH0276815A (fr)
AU (1) AU633496B2 (fr)
BE (1) BE1002295A5 (fr)
CA (1) CA1330306C (fr)
CH (1) CH679553A5 (fr)
DE (1) DE3922263A1 (fr)
DK (1) DK336489A (fr)
FR (1) FR2633831B1 (fr)
GB (2) GB8816187D0 (fr)
IT (1) IT1232155B (fr)
NL (1) NL8901727A (fr)
SE (1) SE8902458L (fr)
ZA (1) ZA895142B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2112487C (fr) * 1991-06-26 2003-04-15 James W. Young Methode et compositions pour le traitement des vomissements, des nausees et d'autres troubles a l'ondansetron optiquement pur r(+)
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
CZ20031397A3 (cs) * 2000-10-30 2003-11-12 Teva Pharmaceutical Industries Ltd. Nové krystalické a solvatované formy ondansetron hydrochloridu a způsoby jejich přípravy
US7098345B2 (en) * 2002-04-29 2006-08-29 TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
WO2004010955A2 (fr) * 2002-07-31 2004-02-05 Sepracor Inc. Coupe-faims a base d'inhibiteurs de la cyclo-oxygenase-2
EP2124897A4 (fr) * 2006-12-22 2012-05-09 Novadel Pharma Inc Préparations antinauséeuses à pulvériser, à usage oral, stables, et méthodes associées

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105193A (en) * 1981-09-04 1983-03-23 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
EP0272876B1 (fr) * 1986-12-17 1993-10-13 Glaxo Group Limited Application des dérivés hétérocycliques pour la fabrication de médicaments

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB105193A (en) * 1916-08-29 1917-04-05 Thomas Joseph Mills Improvements in Rotary Printing Machines.
AU528310B2 (en) * 1978-11-16 1983-04-21 Beecham Group Plc Composition of paracetamol and metoclopramide
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
EP0201165B1 (fr) * 1985-03-14 1994-07-20 Beecham Group Plc Médicaments pour le traitement de l'éméticité
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105193A (en) * 1981-09-04 1983-03-23 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
EP0272876B1 (fr) * 1986-12-17 1993-10-13 Glaxo Group Limited Application des dérivés hétérocycliques pour la fabrication de médicaments

Also Published As

Publication number Publication date
GB8915499D0 (en) 1989-08-23
CH679553A5 (fr) 1992-03-13
IT8948163A0 (it) 1989-07-06
IT1232155B (it) 1992-01-25
GB8816187D0 (en) 1988-08-10
FR2633831B1 (fr) 1993-11-19
NL8901727A (nl) 1990-02-01
SE8902458D0 (sv) 1989-07-06
ZA895142B (en) 1990-06-27
SE8902458L (sv) 1990-01-08
AU633496B2 (en) 1993-02-04
CA1330306C (fr) 1994-06-21
JPH0276815A (ja) 1990-03-16
GB2220352B (en) 1992-03-18
US4983621A (en) 1991-01-08
FR2633831A1 (fr) 1990-01-12
AU3790489A (en) 1990-01-11
GB2220352A (en) 1990-01-10
DK336489D0 (da) 1989-07-06
DK336489A (da) 1990-01-08
DE3922263A1 (de) 1990-01-11

Similar Documents

Publication Publication Date Title
BE1002249A4 (fr) Compositions pharmaceutiques.
IL119627A0 (en) Controlled-release pharmaceutical preparations
EA200101026A1 (ru) Предварительно желатинированный крахмал в композиции с контролируемым высвобождением
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
CA2326517A1 (fr) Nouvelles formes galeniques de meloxicame a administrer par voie orale
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
HUP0100867A2 (hu) Celecoxib tartalmú gyógyászati készítmények
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
BE1002295A5 (fr) Medicaments.
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
KR880007073A (ko) 의 약 품
KR880007074A (ko) 의약품
IE894049L (en) Therapeutically active substituted benzimidazole and process¹for its preparation
NO20001828D0 (no) Metode for å forhindre nefrotoksisitet forårsaket av cyklosporiner og tacrolimus
BE1002255A5 (fr) Medicaments.
FR2660192B1 (fr) Formulation liposomiales pour l'administration topique ou vaginale de medicaments.
CA2135179A1 (fr) Compositions pharmaceutiques d'agonistes 5ht1 de type alkylsulfonamides, pour administration rectale
BE1002256A3 (fr) Medicaments.
BE1002182A5 (fr) Compositions pharmaceutiques.
JPH0314812B2 (fr)
GEP20043377B (en) Pharmaceutical Complex
HUP9901935A2 (hu) Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet
CA2259270A1 (fr) Preparation pharmaceutique contenant du nimesulide pour administration orale
CA2180837A1 (fr) Microgranules de derives de 5-nitro imidazole
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: GLAXO GROUP LTD

Effective date: 19950731